![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Increased Mortality and the Medicare Disability Eligibility Status of the HCV Population in the US
|
|
|
" Medicare beneficiaries with HCV have almost 5 times the annual mortality of non-diagnosed beneficiaries" from Jules: and the care costs for last year of life are high - $100,000 - which is much higher than treatment cost - therefore all should be identified and treated early
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Gabriela Dieguez1, Bruce Pyenson1, Steven E Marx2, Yuri Sanchez Gonzalez2
1 Milliman Inc.
2 AbbVie Inc.
![HIV1](../images/112116/112116-5/HIV1.gif)
![HIV2](../images/112116/112116-5/HIV2.gif)
![HIV3](../images/112116/112116-5/HIV3.gif)
![HIV4](../images/112116/112116-5/HIV4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|